MARATTO

article · Microorganisms

Identification, Genotyping and Antimicrobial Susceptibility Testing of Brucella spp. Isolated from Livestock in Egypt

201941 citationsOpen accessKafr el-Sheikh University

In plain language

Brucellosis is a contagious zoonotic disease that affects both livestock productivity and public health. An investigation into thirty-four suspected Brucella isolates recovered from cattle, buffaloes, sheep, and goats across nine districts in Egypt confirmed twenty-nine isolates using microbiological profiling, mass spectrometry, and polymerase chain reaction assays. The confirmed strains consisted of eight Brucella abortus biovar 1 and twenty-one Brucella melitensis biovar 3 isolates. Antimicrobial susceptibility testing revealed widespread resistance to several clinical drugs, notably ciprofloxacin, erythromycin, imipenem, and rifampicin. Molecular analysis detected mutations in the rpoB gene across all phenotypically rifampicin-resistant isolates, as well as gyrA and gyrB mutations in four ciprofloxacin-resistant Brucella melitensis isolates. These results characterise the phenotypic resistance and underlying genetic mechanisms of Brucella strains circulating in Egyptian livestock.

Key takeaways

  • Twenty-nine Brucella isolates from Egyptian livestock were identified as Brucella abortus biovar 1 and Brucella melitensis biovar 3.
  • Brucella melitensis isolates showed high resistance to ciprofloxacin and imipenem at 76.2 percent, and rifampicin at 66.7 percent.
  • Brucella abortus isolates exhibited 87.5 percent resistance to erythromycin and 37.5 percent resistance to rifampicin.
  • Mutations in the rpoB gene were identified in all rifampicin-resistant isolates, representing the first report of these mutations in Egyptian Brucella abortus.
  • Mutations associated with ciprofloxacin resistance were identified in the gyrA and gyrB genes of four Brucella melitensis isolates.

Why it matters

Brucellosis poses severe threats to livestock productivity and can transmit directly to humans, causing chronic illness. The high prevalence of resistance to critical therapeutic drugs, including rifampicin and ciprofloxacin, complicates standard treatment regimens in both veterinary and human healthcare. Uncovering the genetic mechanisms driving this resistance provides essential baseline evidence for public health agencies and veterinarians to track and manage zoonotic disease spread.

Commercialisation angle

This research represents early-stage epidemiological and molecular surveillance rather than a deployable technology. The identified gene mutations could inform developers of veterinary diagnostic assays seeking to design molecular tests that detect drug-resistant Brucella strains. Nevertheless, the abstract focuses entirely on isolate characterisation and does not indicate a direct commercialisation pathway.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

Brucellosis is a highly contagious zoonosis worldwide with economic and public health impacts. The aim of the present study was to identify <i>Brucella</i> (<i>B</i>.) spp. isolated from animal populations located in different districts of Egypt and to determine their antimicrobial resistance. In total, 34-suspected <i>Brucella</i> isolates were recovered from lymph nodes, milk, and fetal abomasal contents of infected cattle, buffaloes, sheep, and goats from nine districts in Egypt. The isolates were identified by microbiological methods and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS). Differentiation and genotyping were confirmed using multiplex PCR for <i>B. abortus</i>, <i>Brucella melitensis</i>, <i>Brucella ovis</i>, and <i>Brucella suis</i> (AMOS) and Bruce-ladder PCR. Antimicrobial susceptibility testing against clinically used antimicrobial agents (chloramphenicol, ciprofloxacin, erythromycin, gentamicin, imipenem, rifampicin, streptomycin, and tetracycline) was performed using E-Test. The antimicrobial resistance-associated genes and mutations in <i>Brucella</i> isolates were confirmed using molecular tools. In total, 29 <i>Brucella</i> isolates (eight <i>B. abortus</i> biovar 1 and 21 <i>B. melitensis</i> biovar 3) were identified and typed. The resistance of <i>B. melitensis</i> to ciprofloxacin, erythromycin, imipenem, rifampicin, and streptomycin were 76.2%, 19.0%, 76.2%, 66.7%, and 4.8%, respectively. Whereas, 25.0%, 87.5%, 25.0%, and 37.5% of <i>B. abortus</i> were resistant to ciprofloxacin, erythromycin, imipenem, and rifampicin, respectively. Mutations in the <i>rpo</i>B gene associated with rifampicin resistance were identified in all phenotypically resistant isolates. Mutations in <i>gyr</i>A and <i>gyr</i>B genes associated with ciprofloxacin resistance were identified in four phenotypically resistant isolates of <i>B. melitensis</i>. This is the first study highlighting the antimicrobial resistance in <i>Brucella</i> isolated from different animal species in Egypt. Mutations detected in genes associated with antimicrobial resistance unravel the molecular mechanisms of resistance in <i>Brucella</i> isolates from Egypt. The mutations in the <i>rpo</i>B gene in phenotypically resistant <i>B. abortus</i> isolates in this study were reported for the first time in Egypt.

Research topics

  • Brucella: diagnosis, epidemiology, treatment
  • Escherichia coli research studies
  • Galectins and Cancer Biology

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.3390/microorganisms7120603

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.